0001752724-20-205280.txt : 20201013 0001752724-20-205280.hdr.sgml : 20201013 20201013090241 ACCESSION NUMBER: 0001752724-20-205280 CONFORMED SUBMISSION TYPE: N-CEN PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20200731 FILED AS OF DATE: 20201013 DATE AS OF CHANGE: 20201013 EFFECTIVENESS DATE: 20201013 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AB CAP FUND, INC. CENTRAL INDEX KEY: 0000081443 IRS NUMBER: 132625045 STATE OF INCORPORATION: DE FISCAL YEAR END: 0731 FILING VALUES: FORM TYPE: N-CEN SEC ACT: 1940 Act SEC FILE NUMBER: 811-01716 FILM NUMBER: 201234850 BUSINESS ADDRESS: STREET 1: ALLIANCEBERNSTEIN LP STREET 2: 1345 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 10105 BUSINESS PHONE: 2129691000 MAIL ADDRESS: STREET 1: ALLIANCEBERNSTEIN LP STREET 2: 1345 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 10105 FORMER COMPANY: FORMER CONFORMED NAME: ALLIANCEBERNSTEIN CAP FUND, INC. DATE OF NAME CHANGE: 20110524 FORMER COMPANY: FORMER CONFORMED NAME: ALLIANCEBERNSTEIN CAP FUND,INC DATE OF NAME CHANGE: 20040908 FORMER COMPANY: FORMER CONFORMED NAME: ALLIANCEBERNSTEIN SMALL CAP GROWTH FUND INC DATE OF NAME CHANGE: 19931001 0000081443 S000010309 AB Small Cap Growth Portfolio C000028521 Class A QUASX C000028522 Class B QUABX C000028523 Class C QUACX C000028524 Advisor Class QUAYX C000028525 Class R QUARX C000028526 Class K QUAKX C000028527 Class I QUAIX C000159958 Class Z QUAZX N-CEN 1 primary_doc.xml X0303 N-CEN LIVE 0000081443 XXXXXXXX 811-01716 false false false N-1A S000010309 C000028523 C000028527 C000028524 C000159958 C000028522 C000028521 C000028526 C000028525 AB CAP FUND, INC. 811-01716 0000081443 549300I24E20QB4B6Y20 ALLIANCEBERNSTEIN LP 1345 AVENUE OF THE AMERICAS NEW YORK 10105 US-NY US 212-969-1000 State Street Bank and Trust Company 1 Lincoln Street Boston 02111 617-786-3000 Custody and Accounting Records Brown Brothers Harriman & Co. 50 Post Office Square Boston 02110 617-772-1818 Custody and Accounting Records N N N-1A 15 Y Carol C. McMullen 000000000 N Michael J. Downey 000000000 N Garry L. Moody 000000000 N Robert M. Keith 002309907 Y Jorge A. Bermudez 000000000 N Nancy P. Jacklin 000000000 N Earl D. Weiner 000000000 N Jeanette Loeb 000000000 N Marshall C. Turner, Jr. 000000000 N Vincent S. Noto 000000000 1345 Avenue of the Americas New York 10105 XXXXXX N N N N N N AllianceBernstein Investments, Inc. 8-30851 000014549 0000000000 Y N Ernst & Young LLP 42 00000000000000000000 N N N N N N AB Small Cap Growth Portfolio S000010309 549300DUMEQYBRQHJC25 N 9 0 0 N/A N N Y N N State Street Bank and Trust Company 571474TGEMMWANRLN572 N N Revenue sharing split 540731251.37000000 3438283.00000000 Rule 32a-4 (17 CFR 270.32a-4) Rule 12d1-1 (17 CFR 270.12d1-1) Rule 22d-1 (17 CFR 270.22d-1) Rule 17e-1 (17 CFR 270.17e-1) Y Y N N AllianceBernstein L.P. 801-56720 000108477 0JK55UGWSWNF3X7KLQ85 N AllianceBernstein Investor Services, Inc. 084-01187 0000000000 Y N N Bloomberg L.P. 549300B56MD0ZC402L06 N Standard & Poor's Financial Services LLC 549300U4VWNITEKO2881 N PricingDirect Inc. 549300WIC0TOJ7N7GD54 N ICE Data Services, Inc. 13-3668779 Tax ID N Refinitiv US Holdings Inc. 549300NF240HXJO7N016 N IHS Markit Ltd. 549300HLPTRASHS0E726 GB N Vertical Management Systems, Inc. 27-3275288 Tax ID N N State Street Bank and Trust Company 571474TGEMMWANRLN572 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) State Street Bank and Trust Company (Edinburgh, GB, Branch) 571474TGEMMWANRLN572 GB N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) UBS Switzerland AG 549300WOIFUSNYH0FL22 CH N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) N AllianceBernstein Investor Services, Inc. 0000000000 Y N N AllianceBernstein L.P. 0JK55UGWSWNF3X7KLQ85 Y N N Sanford C. Bernstein Limited N/A 000000000 54930049G8WQ5OOUSD19 GB 0.00000000 Sanford C. Bernstein & Co., LLC 8-52942 000104474 549300I7JYZHT7D5CO04 0.20000000 Citation Group Ltd. 8-43632 000028305 00000000000000000000 76602.50000000 Morgan Stanley & Co. LLC 8-15869 000008209 9R7GPTSO7KV3UQJZQ078 112786.72000000 Goldman Sachs & Co. LLC 8-129 000000361 FOR8UP27PHTHYVLBNG30 283502.69000000 Credit Suisse Securities (USA) LLC 8-422 000000816 1V8Y6QCX6YMJ2OELII46 88616.91000000 Liquidnet, Inc. 8-52461 000103987 213800HSKBBO1GCVRG79 54319.66000000 UBS Securities LLC 8-22651 000007654 T6FIZBDPKLYJKFCRVK44 73924.67000000 Barclays Capital Inc. 8-41342 000019714 AC28XWWI3WIBK2824319 59166.61000000 J.P. Morgan Securities LLC 8-35008 000000079 ZBUT11V806EZRVTWT807 108887.82000000 Citigroup Global Markets Inc. 8-8177 000007059 MBNUM2BPBDO7JBLYG310 23981.39000000 Cowen and Company, LLC 8-22522 000007616 549300WR155U7DVMIW58 94973.66000000 1115820.65000000 Barclays Capital Inc. 8-41342 000019714 AC28XWWI3WIBK2824319 15699567.00000000 RBC Capital Markets, LLC 8-45411 000031194 549300LCO2FLSSVFFR64 15627005.00000000 Credit Suisse Securities (USA) LLC 8-422 000000816 1V8Y6QCX6YMJ2OELII46 18762266.25000000 Goldman Sachs & Co. LLC 8-129 000000361 FOR8UP27PHTHYVLBNG30 44617494.50000000 Morgan Stanley & Co. LLC 8-15869 000008209 9R7GPTSO7KV3UQJZQ078 48787257.50000000 SVB Leerink LLC 8-48535 000039011 549300AAH7U76CEUBI94 5878716.00000000 National Financial Services LLC 8-26740 000013041 549300JRHF1MHHWUAW04 7289249.50000000 Bofa Securities, Inc. 8-69787 000283942 549300HN4UKV1E2R3U73 66988726.75000000 State Street Bank and Trust Company N/A 000000000 571474TGEMMWANRLN572 1595870766.38000000 J.P. Morgan Securities LLC 8-35008 000000079 ZBUT11V806EZRVTWT807 85084614.40000000 1905778163.28000000 Y 2337423326.78000000 Committed 325000000.00000000 N N N N true INTERNAL CONTROL RPT 2 NCEN_2184903325283808.txt Report of Independent Registered Public Accounting Firm To the Shareholders and Board of Directors of AB Small Cap Growth Portfolio: In planning and performing our audit of the financial statements of AB Small Cap Growth Portfolio, (the "Fund"), one of the portfolios constituting the AB Cap Fund, Inc., as of and for the year ended July 31, 2020, in accordance with the standards of the Public Company Accounting Oversight Board (United States), we considered the Fund's internal control over financial reporting, including controls over safeguarding securities, as a basis for designing our auditing procedures for the purpose of expressing our opinion on the financial statements and to comply with the requirements of Form N-CEN, but not for the purpose of expressing an opinion on the effectiveness of the Fund's internal control over financial reporting. Accordingly, we express no such opinion. The management of the Fund is responsible for establishing and maintaining effective internal control over financial reporting. In fulfilling this responsibility, estimates and judgments by management are required to assess the expected benefits and related costs of controls. A company's internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. generally accepted accounting principles. A company's internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with U.S. generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of a company's assets that could have a material effect on the financial statements. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. A deficiency in internal control over financial reporting exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company's annual or interim financial statements will not be prevented or detected on a timely basis. Our consideration of the Fund's internal control over financial reporting was for the limited purpose described in the first paragraph and would not necessarily disclose all deficiencies in internal control that might be material weaknesses under standards established by the Public Company Accounting Oversight Board (United States). However, we noted no deficiencies in the Fund's internal control over financial reporting and its operation, including controls over safeguarding securities that we consider to be a material weakness as defined above as of July 31, 2020. This report is intended solely for the information and use of management and the Board of Directors of AB Small Cap Growth Portfolio and the Securities and Exchange Commission, and is not intended to be and should not be used by anyone other than these specified parties. /s/ ERNST & YOUNG LLP New York, New York September 25, 2020